CoChat

A pilot study of the effects of flumazenil on symptoms persisting after benzodiazepine withdrawal

Lader, Malcolm H., Morton, Sally V. · 1992 · Journal of Psychopharmacology

The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.

Abstract

The potential of the benzodiazepine antagonist flumazenil (Ro 15-1788) to lessen persisting benzodiazepine withdrawal symptoms was demonstrated in 11 patients who had been drug free for between 1 month and 5 years. Doses ranging from 0.2 to 2.0 mg divided into three intravenous injections over a few hours relieved long-standing symptoms to varying extents. These included clouded thinking, tiredness, muscular symptoms such as neck tension, cramps and shaking and the characteristic perceptual symptoms of benzodiazepine withdrawal, namely, pins and needles, burning skin, pain and subjective sensations of bodily distortion. Mood disorder, when present, also improved but the reduction in anxiety and depression may have reflected relief of physical symptoms. The onset of maximum response was sometimes delayed by as much as a day but was usually prompt. Side effects were reported to be either absent or typically described as lightheadedness or dizziness, lasted only a few minutes and were usually well tolerated. The benefits last between a few hours and several days despite flumazenil's otherwise short duration of action. However, symptoms did return to varying degrees in most cases, suggesting the need for repeated doses.

Overview

Integrity signals

Registry

Crossref · 10.1177/026988119200600303

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 8

  1. 1990, American Psychiatric Association Task Force Report
  2. Ashton H., 1987, Br Med J, 82, 665
  3. Ball J.A., 1987, Lancet, 463
  4. Committee on Safety of Medicines, 1988, Curr Problems, 21, 1
  5. Dunton A.W., 1988, Eur J Anaesthiol Suppl, 2, 81
  6. Evans S.M., 1990, The effects of flumazenil (Ro 15-1788) following acute and repeated exposures to lorazepam in healthy volunteers
  7. Eysenck H.J., 1975, Manual of the Eysenck personality questionnaire
  8. Rickels K., 1990, Psychopharmacol Bull, 26, 63

Cited by

See all 34

Metadata

Authors
Lader, M. H., & Morton, S. V.
Affiliations
Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
Venue
Journal of Psychopharmacology
Published
1992-05
Volume
6
Issue
3
Pages
357-363
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2061430598
Cited by
33
References
37
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2018: 2 · 2016: 3 · 2015: 4 · 2014: 1 · 2012: 2
FWCI
1.37
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
Keywords
flumazenil, benzodiazepine withdrawal, benzodiazepine antagonists, mood disorders, anxiety, depression, adverse effects, repeated dosing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A pilot study of the effects of flumazenil on symptoms persisting after benzodiazepine withdrawal. https://app.cochat.ai/papers/10.1177/026988119200600303
The paper
Lader, M. H., & Morton, S. V. (1992). A pilot study of the effects of flumazenil on symptoms persisting after benzodiazepine withdrawal. Journal of Psychopharmacology. https://doi.org/10.1177/026988119200600303

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.